TY - JOUR AU - Kazuno, Kei AU - Kinoshita, Hajime AU - Hori, Mariko AU - Yosizaki, Takamichi AU - Tamura, Atsusi AU - Sato, Hiroshige AU - Murata, Seiichiro PY - 2020 DA - 2020/11/08 TI - Endovascular treatment for mycotic aneurysm using pyoktanin- applied devices JO - CVIR Endovascular SP - 55 VL - 3 IS - 1 AB - Mycotic thoracic aortic aneurysm is an extremely rare but serious disease because it can easily rupture and has a high mortality rate. The standard therapy for it comprises graft replacement and debridement using systemic antibiotics; nonetheless, this has a high mortality rate and complications. Endovascular aortic repair is considered a bridging therapy before open surgery. However, we have used it at our institution for the radical treatment of mycotic thoracic aortic aneurysm utilizing pyoktanin (methylrosanilide chloride)-applied devices. Thus, the aim of this study was to report our clinical experience with pyoktanin-applied thoracic endovascular aortic repair for the treatment of mycotic thoracic aortic aneurysm, including its effects. SN - 2520-8934 UR - https://doi.org/10.1186/s42155-020-00151-0 DO - 10.1186/s42155-020-00151-0 ID - Kazuno2020 ER -